You should continue to store the bac water in the refrigerator and away from light
Common Side Effects (Generally Mild): Temporary injection site reactions (redness, slight swelling) Mild fatigue initially (as metabolism adjusts) Occasional flushing or warmth Slight changes in appetite Contraindications and Precautions: Pregnancy or breastfeeding (insufficient safety data) Active cancer (theoretical concerns about growth pathways) Severe kidney or liver disease (requires monitoring) Hypoglycemia risk (monitor if on diabetes medications) Medical Monitoring: At The Lamkin Clinic, we monitor MOTS-C patients with: Baseline metabolic labs (glucose, HbA1c, insulin, lipids) Follow-up testing at 8-12 weeks Body composition analysis Assessment of symptoms and energy levels Adjustment of other medications as metabolism improves Important: MOTS-C should only be used under the guidance of a qualified healthcare provider experienced in peptide therapy
Safety Profile Both peptides have strong preclinical safety profiles
The research-grade material supplied by Koi Peptides is synthesized for in vitro laboratory research only not formulated, packaged, or labeled for human use, and not authorized for any human or veterinary indication
DEXA scan at 24 weeks compared to baseline quantifies the body composition changes
BPC-157: Continue 250-500 mcg twice daily Cryotherapy: Once daily post-activity application Introduce progressive loading appropriate to the injury type Monitor for signs of excessive inflammation (increased pain, swelling, heat) Chronic Condition Management Sustained approach for arthritis, chronic tendinopathy, or recurring injuries
